Disc medicine initiating phase 1b/2 clinical study of DISC-0974 in patients with myelofibrosis (bone marrow fibrosis) with severe anemia

The open examine will consider the potential of DISC-0974, the primary anti-HJV monoclonal antibody (hemojuvelin) to enhance anemia in sufferers with myelofibrosis (bone marrow fibrosis) Given as a once-monthly subcutaneous injection, DISC-0974 is designed to suppress hepcidin, a important driver of anemia in myelofibrosis (fibrosis of the bone marrow) and different inflammatory ailments. DISC-0974 has … Read more